Exclusivity Engineered: AI-Driven eLearning Solutions for Retail & Luxury
Gain efficiency while maintaining human artistry with a hybrid AI-human approach.
Case Study: Multilingual Retail Marketing
New AI Content Creation Solutions for a Sports and Apparel Giant
Human Expertise Blended With Powerful AI
Lionbridge Aurora AI™ is an AI-first global content platform that increases your multilingual content creation and expands your audience with culturally relevant, hyper-personalized content.
Regulatory demands, evolving requirements, and the constant need for accuracy and speed are creating unprecedented challenges in clinical trial labeling.
Initiatives such as Accelerating Clinical Trials in the European Union (ACT EU) are pushing sponsors, Contract Development and Manufacturing Organizations (CDMOs), and clinical supply organizations to accelerate trial start-up and expand multinational studies. However, fragmented workflows and immature operating models often create bottlenecks that hinder scalability, slow site activation readiness, and increase the risk of errors and rework.
This webinar highlighted practical approaches to mature clinical labeling operating models and “language excellence” as an operational capability — standardization, consistency, and validated reuse that support compliant, scalable execution from Master English Label Text (MELT) to Country Label Text (CLT).
Watch our webinar recording and discover how mature clinical labeling models and effective language strategies support compliance, scalability, and high-quality patient outcomes in global studies, thereby promoting timely access to innovative medicines.
You’ll walk away with:
As a special bonus, all registrants will receive access to our comprehensive whitepaper on clinical labeling.
The discussion featured Lionbridge clinical labeling and language experts Mayowa Ojeyomi and Pia Windelov, along with our external regulatory and labeling expert, Martin Koenig.